Abstract:Neuroinflammation is considered a balanced inflammatory response important in the intrinsic repair process after injury or infection. Under chronic states of disease, injury, or infection, persistent neuroinflammation results in a heightened presence of cytokines, chemokines, and reactive oxygen species that result in tissue damage. In the CNS, the surrounding microglia normally contain macrophages and other innate immune cells that perform active immune surveillance. The resulting cytokines produced by these macrophages affect the growth, development, and responsiveness of the microglia present in both white and gray matter regions of the CNS. Controlling the levels of these cytokines ultimately improves neurocognitive function and results in the repair of lesions associated with neurologic disease. MicroRNAs (miRNAs) are master regulators of the genome and subsequently control the activity of inflammatory responses crucial in sustaining a robust and acute immunological response towards an acute infection while dampening pathways that result in heightened levels of cytokines and chemokines associated with chronic neuroinflammation. Numerous reports have directly implicated miRNAs in controlling the abundance and activity of interleukins, TGF-B, NF-kB, and toll-like receptor-signaling intrinsically linked with the development of neurological disorders such as Parkinson’s, ALS, epilepsy, Alzheimer’s, and neuromuscular degeneration. This review is focused on discussing the role miRNAs play in regulating or initiating these chronic neurological states, many of which maintain the level and/or activity of neuron-specific secondary messengers. Dysregulated miRNAs present in the microglia, astrocytes, oligodendrocytes, and epididymal cells, contribute to an overall glial-specific inflammatory niche that impacts the activity of neuronal conductivity, signaling action potentials, neurotransmitter robustness, neuron-neuron specific communication, and neuron-muscular connections. Understanding which miRNAs regulate microglial activation is a crucial step forward in developing non-coding RNA-based therapeutics to treat and potentially correct the behavioral and cognitive deficits typically found in patients suffering from chronic neuroinflammation.

Autophagy in Neuroinflammation: A Focus on Epigenetic Regulation

Classical HDACs in the Regulation of Neuroinflammation.

Epigenetic regulation of autophagy in neuroinflammation and synaptic plasticity

Autophagy and proinflammatory cytokines: Interactions and clinical implications.

Epigenetic Regulation of Neuroinflammation in Parkinson’s Disease

Special issue: Neuroinflammatory pathways as treatment targets in brain disorders autophagic regulation of neuroinflammation in ischemic stroke

Emerging role of non-coding RNAs in neuroinflammation mediated by microglia and astrocytes

Bi-Directional Relationship Between Autophagy and Inflammasomes in Neurodegenerative Disorders

Non-coding RNAs and neuroinflammation: implications for neurological disorders

The Role of the Effects of Autophagy on NLRP3 Inflammasome in Inflammatory Nervous System Diseases

Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases

Interaction between autophagy and the NLRP3 inflammasome in Alzheimer's and Parkinson's disease

Therapeutic Potential of Autophagy in Immunity and Inflammation: Current and Future Perspectives

Neuroinflammation in Parkinson's disease: focus on the relationship between miRNAs and microglia

Non-coding RNAs: The Neuroinflammatory Regulators in Neurodegenerative Diseases

The heterogeneity of microglial activation and its epigenetic and non-coding RNA regulations in the immunopathogenesis of neurodegenerative diseases

The modulatory role of dopamine receptors in brain neuroinflammation

The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets

[Autophagy and Neuronal Diseases].

The role of autophagy in the regulation of neuroinflammation in acute ischemic stroke (review of literature)

Targeting Autophagy to Counteract Neuroinflammation: A Novel Antidepressant Strategy